Oxurion advies
WebApr 12, 2024 · 20,6x. Aantal werknemrs. 27. Percentage vrij verhandelbaar. 44,6%. Meer Financiële cijfers. Bedrijfsprofiel. Oxurion NV is een biofarmaceutische onderneming die standaardtherapieën van de volgende generatie voor oogziekten ontwikkelt waardoor patiënten met diabetisch macula-oedeem (DME) beter hun gezichtsvermogen kunnen … WebOxurion verhoogt kapitaal met 500.000 euro. Negma Group Investment heeft 200 converteerbare obligaties omgezet in aandelen Oxurion. Dit werd vanmorgen …
Oxurion advies
Did you know?
WebNov 21, 2024 · Oxurion ended 2024 with €10 million in available cash, according to its annual report, and added to that total by raising another €10 million in a private placement that closed in March. WebMay 24, 2024 · Oxurion’s THR-687 is of special interest as it employs a novel mechanism of action (MOA), as a selective pan-RGD (arginylglycylaspartic acid) integrin antagonist, to treat diabetic retinopathy and various other vision-threatening retinal pathologies such as DME. At the ARVO annual meeting, data was presented for THR-687’s preclinical study ...
WebShareholder Structure. Oxurion is listed on Euronext Brussels under the symbol OXUR. As of March 28, 2024, Oxurion has a total of 632,659,186 shares outstanding and a total of 3,062,810 outstanding subscription rights, of which 2,847,810 were accepted but unexercised, and 215,000 remain to be assigned. View shareholders history of capital. WebStock OXURION Common Stock BE0003846632 XBRU Euronext Brussels Live Euronext kurser, quotes, realtime prices, charts, grafieken, bedrijfsnieuws, AEX BEL Beurs OXURION …
WebApr 12, 2024 · IEX.nl is hét beleggersplatform van Nederland. Blijf op de hoogte van alle relevante informatie over aandelen en andere beleggingsproducten. Beleggen - Koers - Aandelen - Discussie. WebApr 13, 2024 · De koers van OXURION (Aandeel, BRU) met nieuwsberichten, columns, agenda, forum, technische analyse, fundamentele analyse, opties, turbo's, speeders, …
WebApr 14, 2024 · Beurscodes, betekenis en hulp bij zoeken Europa AEX Euronext Amsterdam BRU Euronext Brussels PSE Euronext Paris LIS Euronext Lissabon CHX CBOE Europe, grote(re) EU aandelen
WebNov 4, 2024 · Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to … horror artist for hireWeb23 hours ago · Winst gevend 14 april 2024 17:50. . Slotkoers € 1.020 met een volume van 5.518 miljoen stuks (-1.54 %) _Nabeurs € 1.018 met een volume van 5.841 miljoen stuks (-1.73 %) En hiermee is vlak na ... horror anthology show hbo african americanWebMay 9, 2024 · Shares in Belgian biotech Oxurion are taking a hammering this morning after it reported that one of its drugs for diabetic eye disease had failed a phase 2 trial and will be terminated. The ... horror apocalypse nowWebOxurion is een Belgisch gevestigd bedrijf dat onderzoek voert naar geneesmiddelen voor oogaandoeningen. In 2006 kwam de firma tot leven als ‘ Thrombogenics ’, maar de … horror art black and whiteWebFeb 8, 2024 · Oxurion is currently conducting a Phase 2 clinical trial (“INTEGRAL”) evaluating THR-687 in patients with DME. THR-687 also has the potential to deliver improved treatment outcomes for ... lower brisbane river catchmenthorror artist vs disneyWebMar 17, 2015 · Vind jij het leuk om professioneel advies te… Liked by Philip Corens Pinchart. Antwerp Cargo Movers, a fast-growing and successful company from Antwerp, can now call off its search for a new shareholder. ... Oxurion is pleased to participate in the virtual Degroof Petercam Healthcare Conference. CEO Tom Graney is hosting meetings with ... horror artist polish